10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-047780`
Period End Date	20150630
Filing Date	20150810
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	lbio-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 36 Cash Flow Statement 45 Stockholders Equity 17 Comprehensive Income 12

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$529.87K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$104.22K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Money market funds	`MoneyMarketFundsAtCarryingValue`	$7.48M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	3,694.00	shares	Point-in-time
Money market funds	`MoneyMarketFundsAtCarryingValue`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	5,694.00	shares	Point-in-time
Short-term investments available for sale	`AvailableForSaleSecurities`	$92.30M	USD	Point-in-time
Short-term investments available for sale	`AvailableForSaleSecurities`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	3,694.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	5,694.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$378.41K	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$66.13K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$44.98M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$112.71M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.14M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $529,866 and $104,223	`PropertyPlantAndEquipmentNet`	$2.03M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $529,866 and $104,223	`PropertyPlantAndEquipmentNet`	$1.53M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	33.75M	shares	Point-in-time
Total Assets	`Assets`	$46.51M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.14M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	33.75M	shares	Point-in-time
Total Assets	`Assets`	$114.74M	USD	Point-in-time
Common stock to be issued shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Common stock to be issued shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.25M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$623.77K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$327.85K	USD	Point-in-time
Accrued payable to officers and former directors	`AccountsPayableRelatedPartiesCurrent`	$85.50K	USD	Point-in-time
Accrued payable to officers and former directors	`AccountsPayableRelatedPartiesCurrent`	$85.50K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.87M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.66M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively	`PreferredStockValue`	$4.00	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively	`PreferredStockValue`	$6.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 47,140,195 and 33,750,188 shares issued and outstanding, respectively	`CommonStockValue`	$1.41K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 47,140,195 and 33,750,188 shares issued and outstanding, respectively	`CommonStockValue`	$1.96K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.15K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.15K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$21.70K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$200.83M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$121.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-88.23M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$44.85M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$112.87M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$46.51M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$114.74M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	2 Qtrs
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	2 Qtrs
Revenues	`Revenues`	-	USD	1 Quarter
Operating expenses	`OperatingCostsAndExpenses`	$4.90M	USD	2 Qtrs
Operating expenses	`OperatingCostsAndExpenses`	$1.62M	USD	1 Quarter
Operating expenses	`OperatingCostsAndExpenses`	$2.38M	USD	1 Quarter
Operating expenses	`OperatingCostsAndExpenses`	$3.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.84M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.22M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.06M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$493.99K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.11M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$4.37M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$6.44M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$11.74M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-11.74M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.37M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.44M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$72.73K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$72.73K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	-	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.67M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-4.37M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	22.50M	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	45.08M	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	41.41M	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.14M	shares	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.37M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$17.73K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$425.64K	USD	2 Qtrs
Fair value of vested stock options	`StockOptionPlanExpense`	$2.30M	USD	2 Qtrs
Fair value of vested stock options	`StockOptionPlanExpense`	$1.34M	USD	2 Qtrs
Vesting of restricted shares issued for services	`FairValueOfVestedWarrantsGrantedForServices`	$1.09M	USD	2 Qtrs
Vesting of restricted shares issued for services	`FairValueOfVestedWarrantsGrantedForServices`	$440.75K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$312.27K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-94.51K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-1.11M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$204.44K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.96M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.59M	USD	2 Qtrs
Increase in money market funds	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	2 Qtrs
Increase in money market funds	`IncreaseDecreaseInOtherCurrentAssets`	$7.48M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$96.28M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	-	USD	2 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	-	USD	2 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$4.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$919.13K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.74K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.74K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-100.68M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$2.36M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$7.98M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$32.20M	USD	Point-in-time
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$68.31M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.36M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$76.28M	USD	2 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-32.35M	USD	2 Qtrs
Net Decrease In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.23M	USD	2 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.44M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.56M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.44M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.56M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Common stock issued upon conversion of preferred stock	`DebtConversionOriginalDebtAmount1`	$42.00	USD	2 Qtrs
Common stock issued upon conversion of preferred stock	`DebtConversionOriginalDebtAmount1`	-	USD	2 Qtrs

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$44.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$112.87M	USD	Point-in-time
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalMarkToMarket`	$2.30M	USD	2 Qtrs
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$7.98M	USD	2 Qtrs
Common stock issued upon conversion of preferred shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	2 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueOther`	$68.31M	USD	2 Qtrs
Vesting of restricted shares issued for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition`	$1.09M	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$21.70K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$21.70K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.37M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Balance	`StockholdersEquity`	$44.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$112.87M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-6.37M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.67M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-4.37M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$21.70K	USD	2 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$21.70K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-6.35M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-2.11M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-11.64M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-4.37M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.